Discover more about how AI models can accurately distinguish children with autism spectrum disorder using eye-tracking ...

Soluble α2δ-1 may restore brain balance and reverse schizophrenia deficits. Discover this potential therapeutic breakthrough.

Eli Lilly won FDA approval on 1 April 2026 for a once-daily oral GLP-1, orforglipron. Read more about the drug and its ...

TENS significantly reduces movement related pain in fibromyalgia, with sustained benefits and strong patient reported ...

Hospital crisis decision-making may protect preparedness but sideline other services during emergencies. Read more.

Stopping RAS inhibitors after eGFR decline may raise risk of kidney failure and death. Learn more about this new study.

Hospital-acquired pneumonia remains a major ICU threat as new diagnostics and tailored treatment strategies reshape care.

Read more about the settings in which applying antiseptics to the umbilical cord can reduce infection and mortality risk.

Lupus nephritis biomarkers show promise, but most lack strong evidence for clinical use. Read more on key findings.

New urinary biomarkers show promise for bladder cancer detection and recurrence prediction. Learn more about this non-invasive diagnostic approach.

Semaglutide is set to be offered to more than one million people with cardiovascular disease on the NHS in coming months.

Rapid testing identifies acute respiratory distress syndrome subtypes linked to mortality, supporting precision medicine in ...